DAR's Q2 Profit Jumped to $387 Million-Collagen Growth and Renewable Diesel Margins Set the Next Move

Darling's Q2 beat shifts the debate from value to durability

This quarter changes the conversation. Darling now looks less like a simple "cheap stock" trade and more like a test of earnings durability: can a business that posted $2.41 GAAP EPS on $1.72 billion of revenue sustain that profit level, or was this mostly a very good quarter from a cyclical operator?

The surprise was large enough to force a reassessment. Darling reported roughly $1.72 billion in revenue, $2.41 of GAAP EPS versus $1.37 expected, and about $741.7 million of adjusted EBITDA versus $509.3 million expected. In practical terms, Wall Street had a decent quarter in mind; Darling delivered something much stronger. That shifts the question from "Is it undervalued?" to "How much of this should we treat as more persistent?"

Why bulls see a higher profit base

Bulls will argue this was not just a one-off. Net income rose to $387 million, adjusted EBITDA reached about $742 million, and Diamond Green Diesel remained a major contributor, with $389 million of EBITDA and roughly $280 million in cash distributions. If renewable diesel margins stay healthy and ingredient markets remain supportive, investors now have a much firmer earnings floor to work with.

Why bears still see vulnerability

Bears will note that the quarter still looks exposed to commodity swings and trade-related benefits, including favorable tariff recoveries. If the result was driven more by temporary pricing tailwinds than by structural improvement, the stock could de-rate quickly when conditions normalize.

The key issue now is not whether Darling had a strong quarter. It is whether that strength is repeatable.

Margin expansion, not just sales growth, drove the result

That earnings surprise was really a margin surprise. Sales grew, but the bigger story was profitability: operating margin at 32.2% versus 5.1% a year earlier. That is the difference between a business that is simply busier and one that is keeping much more of each sales dollar.

Why profit grew faster than revenue

The mechanics are straightforward. When prices improve faster than costs, profit does not grow in line with sales; it grows faster. Darling's quarter fit that pattern. Management pointed to stronger ingredient markets, operational gains, stronger finished-product markets, and rising fat and protein prices. This was not just more volume. It was a wider spread between input costs and selling prices.

You can see the same logic inside the businesses. Darling's core ingredients unit produced about $353 million of adjusted EBITDA, up from $207 million a year earlier. The broader take-away is that better pricing for usable by-product streams, not financial engineering, helped expand the profit pool.

Diamond Green Diesel did much of the heavy lifting

The clearest proof that margins-not just sales-took the quarter came from renewable fuels. Diamond Green Diesel contributed $389 million of EBITDA and benefited from favorable tariff recoveries. Bears are right to flag that trade-related benefits can fade. But even allowing for that, the fact that one segment produced that level of operating profit while the rest of the business also improved suggests Darling's earning power is more flexible than the market may have assumed.

The watchpoint is repetition. If fat and protein pricing, ingredient demand, and renewable diesel margins stay healthy, investors will be more likely to treat this quarter as the start of a stronger baseline rather than a lucky break.

Nextida and collagen are becoming the longer-term valuation lever

Q2 showed Darling can turn an ordinary quarter into a profit surprise. The next question is where that added confidence goes. Increasingly, the answer is collagen.

Why the Nextida combination matters

The market may start valuing Darling less like a pure cyclical processor and more like a specialty-ingredient platform. The clearest signpost is Nextida. The proposed combination with Tessenderlo is expected to create a approximately $1.5 billion revenue company in collagen-based health, nutrition, and food applications, with Darling holding an 85% ownership stake. That is a material piece of the story, not a marginal side initiative.

This also builds on a platform Darling already claims. The company says it has achieved global leadership in rendering and collagen, and it is backing that position with expansion plans driven by capacity constraints. In simple terms, Darling is investing more heavily in the business line where demand already appears strong.

Why the market could pay up for collagen

The appeal is the profit mix. Darling has argued that Nextida products can earn substantially more than traditional gelatin, and earlier this year it secured a U.S. patent for Nextida GC. That pushes the collagen story toward differentiated functionality, not just another commodity output.

The company is also planning for more than a narrative. Darling says it is planning 20 to 30 new factories globally over the next 3 to 5 years. When management expands capacity on that scale, it usually signals confidence that demand is building faster than current supply can handle.

What could confirm or weaken the collagen case

Bulls will say collagen is becoming the part of the story the market values most because it can improve the quality and stability of Darling's earnings. A larger, higher-margin, more differentiated collagen business is generally easier to underwrite than a company living only from commodity cycles.

Bears will say the transaction is still a combination on paper, not yet closed, and that new capacity only pays off if demand holds. That is the right watchpoint. If closure slips or expansion outruns real demand, the premium case weakens quickly. If those execution hurdles clear, though, investors could start assigning more value to collagen before the full contribution shows up in reported numbers.

What investors need to see over the next few quarters

At a market capitalization of $9.32 billion, DAR is no longer asking investors to imagine hidden value out of thin air. It is asking them to underwrite durability against a benchmark built on $1.72 billion of revenue and $741.7 million of adjusted EBITDA. That is a high bar to defend.

What the market is really pricing in

The bull case works if Darling's current profit engines keep supporting the story while collagen builds credibility. That means healthy renewable diesel margins need to keep supporting Diamond Green Diesel, rising fat and protein prices need to keep helping ingredients, and the market needs to get more comfortable with Nextida as the specialty-ingredient path moves closer to reality. The recent U.S. patent granted for Nextida GC helps the narrative, but it does not replace execution.

That is the real decision point now: not whether DAR had one great quarter, but whether the operating mix is stabilizing into a stronger, more durable profit base.